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Purpose: Transobturator approaches to midurethral sling surgery are one of the most 
commonly performed operations for female stress urinary incontinence throughout the 
world. However, very few results of randomized clinical trials of transobturator mid-
urethral sling surgery (MONARC vs. TVT-O) for the treatment of female urinary incon-
tinence have been reported. In this study, we compared the 3-year follow-up cure rates 
of these two procedures.
Materials and Methods: From July 2006 to June 2008, 74 patients who had undergone 
MONARC (35 patients) or TVT-O (39 patients) were included in the study and were 
analyzed prospectively. The mean follow-up duration of both groups was 39.2 months. 
Preoperative and postoperative evaluations included physical examination, uro-
flowmetry and postvoid residual measurement, involuntary urine loss with physical 
activity, and urinary symptoms. Cure of female urinary incontinence was defined as 
patient report of no loss of urine upon physical activity. The patients’ satisfaction after 
treatment was rated as very satisfied, satisfied, equivocal, and unsatisfied. Very sat-
isfied and satisfied were considered as the satisfied rate. 
Results: There were no significant differences in preoperative patient characteristics, 
postoperative complications, or success rate between the two groups. The cure rate of 
the MONARC and TVT-O groups was 85.7% and 84.6%, respectively. The patient sat-
isfaction (very satisfied, satisfied) rate of the MONARC and TVT-O groups was 82.8% 
and 82.1%, respectively. 
Conclusions: The MONARC and TVT-O procedures were equally efficient for the treat-
ment of female urinary incontinence, with maintenance of high cure rates for 3 years. 
Longer follow-up is needed to confirm these results.
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INTRODUCTION
Stress urinary incontinence (SUI) is the most common type 
of urinary incontinence in females, in which the in-
voluntary leakage of urinary flow occurs as abdominal 
pressure increases and the bladder neck opens, caused by 
hyperkinesia of the urethra and dysfunction of the urethral 
sphincter. In Korea, 37.8% of women suffer from SUI, and 
there is increasing interest in improved quality of life for 
patients, leading to aggressive treatment strategies [1].
Retropubic suburethral tension-free vaginal tape (TVT) 
has revolutionized the treatment of SUI [2,3]. The techni-
que, which is effective, is nonetheless associated with a risk 
of complications [4]. Complications related to the retro-
pubic access route, such as wound infection, urethral in-
fection, hematoma, bladder perforation, gastrointestinal 
injury, and vascular or nerve injury, can occur, and in seri-
ous condition can be fatal [2,5]. In 2001, a surgical techni-Korean J Urol 2012;53:258-262
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TABLE 1. Preoperative comparisons between patients who 
underwent MONARC and TVT-O
MONARC 
(n=35)
TVT-O 
(n=39)
p-value
Age (yr)
Follow-up period (mo)
Parity
BMI (kg/m
2)
Storage symptoms
Frequency (＞8/d)
Nocturia (≥1/night)
Urgency
Urge incontinence
VLPP (cm H2O)
Qmax (ml/s)
Voided volume (ml)
PVR (ml)
  55.1±10.6
39.2±3.1
  2.6±1.1
  25.9±0.48
24
12
22
19
  70.7±23.3
17.7±9.4
441.0±82.3
  29.7±16.2
  54.4±10.1
39.2±2.4
  2.8±1.4
  28.9±0.53
21
  9
25
20
  77.0±25.6
22.2±9.2
487.7±78.6
  28.3±17.9
0.744
a
0.155
a
0.563
a
0.625
a
0.773
b
0.747
b
0.572
b
0.937
b
0.097
a
0.523
a
0.779
a
0.582
a
Values are presented as mean±SD or number (%).
TVT-O, tension-free vaginal tape-obturator; BMI, body mass in-
dex; VLPP, Valsalva leak point pressure; Qmax, maximum flow 
rate; PVR, post void residual.
a: Student’s t-test, 
b: Chi-square test.
que similar to TVT but that reduced the complication rate 
by replacing the retropubic route with the transobturator 
route was proposed. Delorme [6] was the first to describe 
the method of subobturator suburethral suspension 
known as outside-in. More recently, the transobturator 
route has been used, inside-out, with the technique re-
ported by de Leval [7]. The most commonly used methods 
are the MONARC (outside-in, MONARC subfascial ham-
mock, American Medical Systems Inc., Minnetonka, MN, 
USA) and the TVT-O (inside-out, TVT obturator system, 
Ethicon Inc., New Brunswick, NJ). 
The author’s experience with transobturator sub-
urethral slings for the surgical correction of SUI, MONARC 
versus TVT-O, is reported herein with the aim of confirm-
ing the efficacy and safety of the two methods. 
MATERIALS AND METHODS
From July 2006 to June 2008, 74 female patients with SUI 
who underwent the transobturator route procedure at our 
hospital were included in this randomized, prospective, ob-
servational study. A total of 35 patients underwent the 
MONARC procedure and 39 patients underwent the 
TVT-O procedure. 
Preoperatively, patients had a history of voiding symp-
toms such as frequency, urgency, and urge incontinence. 
Frequency was defined as needing to void more than 8 
times a day; urgency was defined as having a sudden, com-
pelling urge to urinate; and urge incontinence was defined 
as a leakage of urine due to bladder muscles that contract 
inappropriately, also showing symptoms of urgency. 
All patients also underwent history taking, pelvic exami-
nation, urinalysis, culture test, uroflowmetry, postvoid re-
sidual, Q-tip test, stress test, and urodynamic study includ-
ing Valsalva leak point pressure (VLPP). Through the pre-
operative physical examination and urodynamic studies, 
patients with neurogenic bladder, pelvic organ prolapse, 
suspected intrinsic sphincter deficiency, or a past history 
of radical pelvic surgery were excluded. 
The procedure was performed by a single surgeon, and 
patients underwent one of the two techniques in accord-
ance with the scheduling order (MONARC and TVT-O, in 
alternation). Cystoscopy was performed to ensure that 
there was no injury to the bladder during the procedure. 
After checking for any bladder injury, we inserted a Foley 
catheter. On postoperative day 1, we removed the catheter 
and residual volume was measured after spontaneous 
voiding. Following the postoperative period, urinary incon-
tinence status and patient satisfaction were examined 
through an interview and physical examination in an out-
patient setting. Patients were considered to be cured if they 
had no symptoms of urinary incontinence after the proce-
dure, were considered to be improved if urinary incon-
tinence was improved after the procedure and no more 
treatment was necessary, and were considered to be un-
changed if the patient reported maintenance of urinary in-
continence and was unsatisfied with the result of surgery. 
The term success rate indicated the sum of the cure and im-
provement rates. Cure was defined as the absence of any 
episodes of involuntary urine leakage during stressful ac-
tivities and a stress test. Improvement was defined as a sig-
nificant reduction in urine leakage, such that it did not re-
quire further treatment. The satisfaction score was classi-
fied into “very satisfied,” “satisfied,” “equivocal,” and 
“unsatisfied” on the basis of the patient’s subjective symp-
toms; very satisfied and satisfied were combined as the sat-
isfied rate. We also checked on postoperative frequency, ur-
gency, urge incontinence, or any other new voiding symp-
toms such as urge urination. Uroflowmetry and postvoid 
residual (PVR) were also measured. 
Statistical analysis of the data was performed by using 
Student’s t-test and chi-square test, for which SPSS ver. 
13.0 (SPSS Inc., Chicago, IL, USA) was used. A p-value of 
＜0.05 was considered statistically significant. 
RESULTS
The MONARC and TVT-O patient groups had a mean age 
of 55.1±10.63 years (range, 35 to 79 years) and 54.4±10.13 
years (range, 31 to 79 years), respectively. The mean fol-
low-up period was 39.2±3.1 months (range, 32 to 44 months) 
in the MONARC group and 39.2±2.4 months (range, 34 to 
45 months) in the TVT-O group. The characteristics of the 
patients are summarized in Table 1. There were no sig-
nificant differences between the two groups.
At 3 years of follow-up, the surgical cure rates were 85.7% 
(30/35) in the MONARC group and 84.6% (33/39) in the 
TVT-O group. Although the cure rate was slightly higher 
in the MONARC group, the difference between the groups 
was not statistically significant. In the MONARC group, Korean J Urol 2012;53:258-262
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TABLE 2. Postoperative comparisons of cure rate and satisfac-
tion rate between patients who underwent MONARC and 
TVT-O
MONARC 
(n=35)
TVT-O 
(n=39)
p-value
a
Cured 
Improved 
Unchanged
Very satisfied
Satisfied
Equivocal
Unsatisfied
30 (85.7)
3 (8.6)
2 (5.7)
16 (45.7)
13 (37.1)
  5 (14.3)
1 (2.9)
33 (84.6)
3 (7.7)
3 (7.7)
20 (51.3)
12 (30.8)
  5 (12.8)
2 (5.1)
0.348
0.627
0.673
0.652
0.734
0.824 
0.809 
Values are presented as number (%).
TVT-O, tension-free vaginal tape-obturator.
a: Chi-square test.
TABLE 3. Postoperative comparisons of cure rate between patients who underwent MONARC and TVT-O
MONARC (n=35) TVT-O (n=39)
1 yr 2 yr 3 yr 1 yr 2 yr 3 yr
Cured 
Improved 
Unchanged 
32 (91.4)
1 (2.9)
2 (5.7)
31 (88.6)
2 (5.7)
2 (5.7)
30 (85.7)
3 (8.6)
2 (5.7)
35 (89.7)
2 (5.1)
2 (5.1)
34 (87.2)
2 (5.1)
3 (7.7)
33 (84.6)
3 (7.7)
3 (7.7)
Values are presented as number (%).
TVT-O, tension-free vaginal tape-obturator.
TABLE 4. Comparison of postoperative complications between 
patients who underwent MONARC and TVT-O
MONARC 
(n=35)
TVT-O 
(n=39)
p-value
a
Voiding difficulty
Vaginal discharge
Dyspareunia
Inner thigh pain
Bladder perforation
Urethral injury
Total
1 (2.9)
1 (2.9)
1 (2.9)
0 (0)
0 (0)
0 (0)
3
1 (2.6)
0 (0)
1 (2.6)
1 (2.6)
0 (0)
0 (0)
3
0.528
0.803
0.865
0.725
0.759
0.674
Values are given as number (%)
TVT-O: tension-free vaginal tape-obturator. 
a: Chi-square test.
five patients showed incontinence postoperatively. Three 
of them showed improvement and two were unchanged. Six 
patients in the TVT-O group showed incontinence postope-
ratively. Three of them showed improvement and three 
were unchanged. Following the MONARC and TVT-O pro-
cedures, the rates of satisfaction were 82.8% (29/35) and 
82.1% (32/39), respectively. Patient’s satisfaction did not 
differ significantly between the groups (Table 2). The surgi-
cal cure rate decreased year after year (Table 3).
In terms of uroflowmetry and PVR, the mean post-
operative maximal flow rate (MFR, ml/s) in the MONARC 
and TVT-O groups was 22.9±10.2 ml/s and 22.1±10.6 ml/s, 
respectively. The mean postoperative PVR in the MONARC 
and TVT-O groups was 23.5±44.1 ml and 23.9±54.2 ml. 
There were no statistically significant observable differ-
ences between the two groups in postoperative residual 
urine. Also, there were no significant complications related 
to MONARC or TVT-O. Two cases of voiding difficulty, a 
case of vaginal discharge, and a case of dyspareunia were 
observed in the MONARC group. In the TVT-O group, there 
were three cases of voiding difficulty, one of dyspareunia, 
and one of pain in the thighs. No bladder perforation or ure-
thral injury was reported in either group. There were no 
statistically significant between-group differences for any 
complications (Table 4).
DISCUSSION
A variety of modalities have been implemented for the 
management of female SUI, such as conservative treat-
ment, drug treatment, and surgical treatment, and it is 
known that surgical treatment is the most effective [8]. 
Following the initial reports by Ulmsten et al. [2] on a new 
surgical procedure to treat SUI, the TVT procedure gained 
worldwide diffusion due both to its mini-invasiveness and 
to its high success rates. Through assessment by use of 
strict objective and subjective outcome measures, cure 
rates of 85% have been reported, with another 5 to 10% 
showing significant improvement [9], and preliminary 
analysis of the 7-year results of Nilsson et al. [10] indicates 
a cure rate of 81%. 
However, because the TVT trocar is directed from the 
vagina to the retropubic area in an essentially blind man-
ner, it can cause bladder injuries and rare but life-threat-
ening injuries to the bowels or large vessels [11,12]. 
Because most of these complications seem to be related to 
the penetration of the retropubic space, a new surgical pro-
cedure that retains the same mid-urethra position as that 
of TVT while maintaining or even improving efficacy by re-
ducing or eliminating the complications related to the pen-
etration of the retropubic space has been invented. 
The transobturator type technique is simpler, easy to 
learn, and has shorter operative and hospitalization times. 
Also, the long-term record of this technique is positive 
enough that it is the most widely used procedure. Delorme Korean J Urol 2012;53:258-262
Randomized 3 Year Follow up Study of MONARC
Ⓡ vs. TVT-O
Ⓡ in Female Urinary Incontinence 261
[6] and Delorme et al. [13] reported in two articles that 
MONARC is a safe and effective surgical procedure for the 
treatment of female SUI, with a 90.6% cure rate and a 9.4% 
improvement rate at 1 year of follow-up. Jeong et al. [14] 
reported that the surgical cure rate was 84.8% (28/33) and 
the rate of patient satisfaction was 78.8% in the MONARC 
group. A study by Costa et al. [15] confirmed the hypothesis 
that MONARC may dramatically reduce intraoperative 
complications by avoiding the retropubic space, indicating 
an overall complication rate of 2.2% (bladder perforation, 
urethral perforations, and number of vaginal lateral perfo-
rations). This rate is far lower than that reported with TVT, 
which can be up to 15% [16]. However, complications such 
as urethral or bladder perforation, vascular damage, and 
vaginal erosion are still reported.
Waltregny et al. [17] reported a prospective study of 
TVT-O implantation in 53 patients. The recovery rate was 
94.3% at the 6-month time point. Only one case was consid-
ered a failure. The only complications consisted of tran-
sient pain for a few patients. Two patients underwent tape 
section due to chronic retention and imperious urges to 
urinate. Rader et al. [18] reported 106 cases of TVT-O 
implantationx. The objective recovery rate was 91.5% with 
4.7% improvements and 3.8% failures. De novo imperious 
urges to urinate were observed in 3.8% of cases. One patient 
required tape repositioning due to complete retention. 
Voiding difficulties with retention problems and de novo 
urge symptoms are the other complications that are most 
frequently associated with anti-incontinence operations. 
Whereas the traditional incontinence operation had an in-
cidence rate of more than 30% [9], TVT has shown post-
operative voiding difficulties of transient urine retention 
in 8 to 17% of patients [19-21] and urgency in 5 to 15% of 
patients [5,20,21]. Delorme [6] reported no postoperative 
voiding difficulties in his research on the use of the trans-
obturator approach. In this study, one patient (2.9%) in the 
MONARC group experienced transient voiding difficulty. 
It has been hypothesized that, with the retropubic ap-
proach, the U-shaped sling kinks the urethra, whereas 
with the obturator approach, the sling is positioned more 
horizontally, thus reestablishing more natural lateral sup-
port and thereby decreasing the risk of postoperative void-
ing difficulties [11].
Liapis et al. [22] have reported that after 1 year of fol-
low-up the rate of complete recovery of the MONARC and 
TVT-O procedures is 90% and 87% each. Lee et al. [23] re-
ported that after 1 year of follow-up on 100 Korean SUI pa-
tients the rate of complete recovery was 92% and 86% each. 
On the other hand, Debodinance [24] reported that after 
follow-up on 100 patients who underwent MONARC or 
TVT-O, the rate of complete recovery was 90% and 94% 
each, which means that the rate of complete recovery was 
a bit higher with the TVT-O procedure. In this study, at 1 
year of follow-up, the complete recovery rate of patients in 
MONARC group was 91.4% and that of the TVT-O group 
was 89.7%. At 3 years of follow-up, the complete recovery 
of the MONARC and TVT-O groups was 85.7% and 84.6% 
each, the improvement rate was 94.3% and 92.3% each, and 
there were no significant differences between the 
MONARC and TVT-O groups. 
The outside-in technique necessitates more marked per-
iurethral dissection because a finger must be used to locate 
the tip of the ancillary in contact with the ischiopubic 
branch. The method does not prevent vesical complications 
even though they are less numerous than with the retro-
pubic technique. The technique may be accompanied by 
urethral lesions, which, while rare, are known to be more 
difficult to manage than is a vesical lesion [15,25]. In the 
results of a multicenter study, Costa et al. [15] also reported 
that out of 183 patients who underwent surgery based on 
the outside-in method, 1 and 2 showed perforation of the 
urinary bladder and damage to the urethra, respectively. 
In contrast, the inside-out technique does not require ex-
tensive dissection and apart from the risk of delivering a 
direct wound to the bladder or urethra during scissor dis-
section, it is not possible to secondarily wound the bladder 
or urethra with the ancillary thanks to the metal guide 
system. It is generally known that after TVT-O patients do 
not need cystoscopy because the technique does not pass 
through the Retzius space and therefore is less likely to 
cause bladder perforation. However, when the tip of an ap-
paratus is inserted obliquely and in the wrong direction, 
it could cause bladder perforation. We carried out cysto-
scopy for every surgery and found no additional compli-
cations. 
Although the inside-out method is known to have a lower 
risk of nerve or blood vessel damage, the procedure must 
be conducted carefully because the distance between the 
obturator canal, which has many obturator vessels and ob-
turator nerves to pass by, and the tunnel instrument is 
short (TVT-O, 19 mm vs. MONARC, 27 mm) [26,27]. In a 
study conducted on seven cadavers, Spinosa et al. [28] 
showed a dangerous proximity between the trajectory of 
TVT-O and the pudendal vascular pedicle, whereas there 
was a safety margin of over 3 cm with the transobturator 
type outside-in technique. Hemorrhagic complications can 
occur intraoperatively during needle insertion. There was 
about a 2 to 4% rate in five studies of TVT [29]. The trans-
obturator suburethral approach has been introduced to 
minimize the risk of complications arising from the retro-
pubic passage of the needle. No significant bleeding or hem-
atoma complication has been reported [30]. 
In this study, there were no intraoperative complications 
and no urethral, bladder, bowel, or vascular injuries. The 
complications reported consisted of recalcitrant pain and 
adductor muscle deficiency creating a risk of disorders of 
gait and standing and preventing crossing of the legs. One 
case of pain causing transient discomfort was observed in 
this study. 
CONCLUSIONS
After a follow-up period of 3 years, the results of this 
randomized, prospective, observational study suggest that Korean J Urol 2012;53:258-262
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both the MONARC and the TVT-O procedure have high 
success rates and low complications and are equally effec-
tive in alleviating female urinary incontinence. 
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